Delivery Order HHSN261201500003I-HHSN26100005
Ended Awarded Last action
- Contract number
- HHSN26100005
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $453,388
Award facts
- Opportunity
-
- N01CO5240180 Solicitation number
- Operations and Technical Support for the Frederick National Laboratory for Cancer Research (FLNCR), a Federally Funded Research and Development Center (FFRDC) Award Notice · Posted Apr 27, 2015
- Contract value 100% obligated
- $453,387.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
- NAICS code
- 561210 Facilities Support Services
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Cost No Fee
- Place of performance
- Frederick, MD 21702, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$48,938 | |
| Funding Only Action | $2,325 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | -$3,500,000 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $4,000,000 |
About this award
This federal contract award, with a ceiling value of $453,387.51, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is a delivery order and is for "CLINICAL STUDIES TO EVALUATE EBOLAVIRUS VACCINES IN W. AFRICA." The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Leidos Biomedical Research Inc. is a Federally Funded Research and Development Center (FFRDC) contractor for the National Cancer Institute (NCI) and has extensive capabilities in biomedical research, clinical trials management, and specialized laboratory services. This award supports critical scientific research across multiple disease areas, including Ebola, and is part of the broader efforts by NIAID to develop and evaluate Ebola virus vaccines.
Quick answers
Who was awarded contract HHSN26100005?
HHSN26100005 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 26, 2015.
How much is contract HHSN26100005 worth?
The government has obligated $453,388 on HHSN26100005.
Which agency awarded contract HHSN26100005?
National Cancer Institute (National Institutes of Health) awarded HHSN26100005, with funding from National Institute of Allergy and Infectious Diseases (National Institutes of Health).
Is contract HHSN26100005 an order under another contract?
Yes. HHSN26100005 is a delivery order under HHSN261201500003I, an indefinite delivery contract.
Was contract HHSN26100005 competed?
The extent of competition for HHSN26100005 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award